Medtronic’s Second Class I Recall This Year Is For HawkOne System
Executive Summary
The US FDA on 21 January gave its highest risk designation to a recall of Medtronic’s HawkOne Directional Atherectomy System. The recall comes on the heels of another class I for the company’s cranial software.